Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

70.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.8K
Oogenesis01:22

Oogenesis

4.5K
Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
4.5K
Infertility in Females01:28

Infertility in Females

4.9K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

7.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.3K
Ovarian Cycle01:27

Ovarian Cycle

4.8K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.8K
Folliculogenesis01:20

Folliculogenesis

3.0K
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Perspective and Needs of Older Adults With Osteoporosis With a Recent Upper Extremity Fragility Fracture Concerning Fall Risk and Fear of Falling.

Journal of geriatric physical therapy (2001)·2026
Same author

Compound Heterozygous Variants in the Phospholipase Gene PNPLA6 Cause Hypopituitarism and Vision Loss.

Human mutation·2026
Same author

ppGpp regulates transcription elongation via direct and indirect inputs to RNA polymerase pausing and nucleotide addition.

bioRxiv : the preprint server for biology·2026
Same author

Workforce and Staffing at 988 Suicide & Crisis Lifeline Centers.

JAMA network open·2026
Same author

Pancreatic arteriovenous malformation: A multi-modal diagnostic approach.

Radiology case reports·2026
Same author

3-D Markerless Tracking of Speech Movements With Submillimeter Accuracy.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2026
Same journal

The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

Southern medical journal·2026
Same journal

α-Gal Syndrome in the South: Why We Need Treatment Trials, Not Just Tick Prevention.

Southern medical journal·2026
Same journal

Association between Main Pancreatic Duct Size, Comorbidities, and Fistula Formation after Whipple Procedure for Pancreatic Cancer.

Southern medical journal·2026
Same journal

Impact of Temperature Variation on Patients with Acute Severe Asthma.

Southern medical journal·2026
Same journal

Assessing the Accuracy and Reliability of ChatGPT-4 to Answer Clinical EHR Messages in Sports Medicine.

Southern medical journal·2026
Same journal

Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

Southern medical journal·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

5.1K

Primary Ovarian Insufficiency: Current Concepts.

Gretchen Collins1, Bansari Patel1, Suruchi Thakore1

  • 1From the Department of Reproductive Biology, Department of Gynecology, Case Western Reserve University, Cleveland, Ohio, and Department of Obstetrics and Gynecology, Wake Forest University, Winston-Salem, North Carolina.

Southern Medical Journal
|March 4, 2017
PubMed
Summary
This summary is machine-generated.

Chemotherapy can cause primary ovarian insufficiency (POI) in young patients, leading to infertility. Hormone replacement therapy is crucial for managing POI symptoms and bone health, but pregnancy is still possible.

More Related Videos

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.7K
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 6, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

5.1K
Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.7K
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

1.1K

Area of Science:

  • Reproductive Endocrinology
  • Oncology
  • Gynecology

Background:

  • Chemotherapy can lead to oocyte destruction, causing primary ovarian insufficiency (POI) in young patients.
  • POI often results in secondary amenorrhea and necessitates hormone replacement therapy (HRT).
  • The chance of pregnancy is typically low in patients with POI.

Purpose of the Study:

  • To discuss the consequences of chemotherapy-induced primary ovarian insufficiency (POI).
  • To outline the management of POI, including hormone replacement therapy (HRT).
  • To address fertility and contraception considerations in young patients with POI.

Main Methods:

  • Review of existing literature on chemotherapy-induced ovarian damage and POI management.
  • Discussion of hormonal and non-hormonal treatment strategies for POI.
  • Analysis of pregnancy risks and contraception needs in POI patients.

Main Results:

  • Hormone replacement therapy (estrogen and progesterone) is standard for POI, supporting development and bone health.
  • Spontaneous ovulation and pregnancy are possible despite POI, necessitating discussion of contraception.
  • Long-term sequelae of POI can be mitigated by early diagnosis, patient education, and emotional support.

Conclusions:

  • POI is a significant consequence of chemotherapy, impacting fertility and requiring HRT.
  • Comprehensive management of POI includes hormonal support, fertility counseling, and contraception discussions.
  • Multidisciplinary care is essential for optimizing outcomes and mitigating long-term health issues in young patients with POI.